FDA Import Refusal 799-2700164-4/21/1 — Bgp Pharma Ulc
The FDA refused shipment 799-2700164-4/21/1 from Bgp Pharma Ulc (Canada) on Jan 6, 2023. The refused product falls under Drugs and Biologics — LEVOTHYROXINE SODIUM (THYROID HORMONE). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jan 6, 2023
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 66JCB01 LEVOTHYROXINE SODIUM (THYROID HORMONE)
- Charges
- 75